2 completed, 2 terminated. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
| Phase 1 | 3 | Terminated 2, Completed 1 |
Follow ricolinostat: new trials by email Literature Review of ricolinostat trials Research Report on ricolinostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy ricolinostat, Placebo - Painful Diabetic Peripheral Neuropathy | Phase 2 | Completed | Regenacy Pharmaceuticals LLC | 282 | 2020-12-07 | 2023-09-21 |
| ACY-1215 for Relapsed/Refractory Lymphoid Malignancies ACY-1215 - Lymphoma, Lymphoid Malignancies | Phase 1 / Phase 2 | Terminated | Jennifer Amengual | 23 | 2014-04-02 | 2024-08-06 |
| ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Terminated | Celgene | 103 | 2014-03-01 | 2025-03-04 |
| Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma ACY-1215 - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Celgene | 120 | 2011-07-01 | 2017-04-06 |
Multiple Myeloma (2) · Blood Protein Disorders (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Lymphoma (1) · Lymphoma, Mantle-Cell (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Neuralgia (1)
Celgene (2) · Jennifer Amengual (1) · Regenacy Pharmaceuticals LLC (1)
United States (4)
Jennifer E Amengual, MD (1) · Sagar Lonial, MD (1)